Retatrutide vs Tirzepatide vs Semaglutide

Understanding the Differences Between Modern Metabolic Therapies and FAQs

GLP-1 based therapies have transformed how providers approach weight management and metabolic health. Several medications now exist that work through similar hormone pathways but with different mechanisms.

The most commonly discussed therapies include Semaglutide, Tirzepatide, and Retatrutide.

Each therapy works slightly differently, and the best option depends on an individual’s health profile and provider evaluation.


Quick Comparison

 

TherapyHormone Pathways TargetedSemaglutideGLP-1TirzepatideGLP-1 + GIPRetatrutideGLP-1 + GIP + Glucagon

 

The number of pathways involved is what differentiates these therapies.


Semaglutide

Semaglutide is one of the most widely known GLP-1 therapies and has been studied extensively for metabolic support.

How it works

Semaglutide mimics the natural GLP-1 hormone involved in:

• appetite regulation
• insulin signaling
• digestive pacing

What providers use it for

Semaglutide is often included in programs designed to support:

• appetite control
• portion management
• metabolic health strategies


Tirzepatide

Tirzepatide builds on the GLP-1 mechanism by targeting two metabolic pathways instead of one.

Hormone pathways

• GLP-1
• GIP

GIP works alongside GLP-1 to influence metabolic signaling and insulin response.

Because of this dual-pathway mechanism, tirzepatide has become one of the most popular therapies in metabolic medicine programs.


Retatrutide

Retatrutide represents a newer generation of metabolic peptide therapy currently being studied.

Hormone pathways

• GLP-1
• GIP
• Glucagon

This triple-agonist mechanism is designed to influence appetite regulation, metabolic signaling, and energy utilization.

Researchers are studying whether activating three pathways may support broader metabolic effects.


Key Differences

Semaglutide

• Single hormone pathway
• GLP-1 receptor activation
• Established metabolic therapy

Tirzepatide

• Dual pathway therapy
• GLP-1 + GIP
• Advanced metabolic signaling support

Retatrutide

• Triple pathway therapy
• GLP-1 + GIP + glucagon
• Emerging next-generation peptide


Which Therapy Is Right For You?

Choosing the right metabolic therapy depends on several factors:

• metabolic health profile
• weight management goals
• medical history
• provider evaluation

At The Well Online, licensed medical providers review each patient individually to determine the most appropriate wellness protocol.


Our Telehealth Process

Step 1

Complete your online health assessment.

Step 2

A licensed provider reviews your medical history and goals.

Step 3

If appropriate, a personalized metabolic therapy program is recommended.


Start Your Consultation

If you're interested in exploring modern metabolic therapies, our team at The Well Online can help guide you through the process.

Start your consultation today to learn which therapy may be right for you.

Frequently Asked Questions

Are peptides supplements?

Some peptides are marketed as supplements or used in cosmetic products. However, the peptides most people are referring to in health, performance, and weight loss conversations are prescription medications—such as GLP-1–based therapies.

These medications are not supplements. They require clinical evaluation, a prescription, and medical oversight.


Is semaglutide a peptide?

Yes. Semaglutide is a peptide-based medication that works by activating the GLP-1 receptor.

It is FDA-approved in specific branded forms and is widely used in medical weight management and metabolic care.


Is tirzepatide a peptide too?

Yes. Tirzepatide is also a peptide-based medication.

It works on both GIP and GLP-1 receptors, offering a dual-action approach, and is FDA-approved in branded versions for metabolic health and weight management.


Are compounded peptide medications FDA-approved?

Compounded medications are not FDA-approved as finished products.

However, compounding itself is a regulated and well-established pharmacy practice. These medications can be legally prescribed and dispensed when created by a licensed pharmacy under a provider’s direction.


So, are compounded medications safe?

A more accurate question is:

“Is this being done through a legitimate medical and pharmacy pathway?”

Compounded medications are commonly used in healthcare. Safety depends on:

  • Proper medical evaluation
  • High-quality, licensed compounding pharmacies
  • Appropriate dosing and protocols
  • Ongoing monitoring and follow-up

At The Well, those standards are non-negotiable.


Why is the FDA talking about GLP-1 medications so much?

Regulators have raised concerns about unapproved GLP-1 products being sold outside of proper medical channels.

In some cases, these products may:

  • Not contain the correct active ingredient
  • Be improperly dosed
  • Come from unreliable or unregulated sources

What this means for you:
It’s not just about what you take—it’s about how you get it. Medical oversight and legitimate pharmacy sourcing matter.


Can you tell me which dose is right for me?

Dosing is always determined by a licensed prescriber based on your individual health profile.

What we do focus on at The Well is helping you maximize your results alongside your medical plan through:

  • Nutrition strategy
  • Protein intake
  • Hydration
  • Strength training
  • Sustainable habit building

What should I eat if my appetite is low?

This is very common with GLP-1–based therapies.

A simple, effective approach:

  • Prioritize protein first
  • Eat smaller, more frequent meals if needed
  • Keep meals simple and consistent
  • Stay ahead of hydration

If symptoms like nausea feel persistent or severe, that’s something to address with your prescriber.


Will I regain weight if I stop?

Weight regain can happen after stopping GLP-1 therapy—especially without supportive lifestyle changes.

That’s why we emphasize:

  • Long-term nutrition habits
  • Strength training
  • Metabolic health
  • Sustainable routines

The goal isn’t just short-term results—it’s keeping them.